Transgene Biotek Ltd. is a biotechnology company located in Medak, India. Founded in 1991 by Dr. Koteswara Rao, it was one of the first biotech companies in the country. Initially focused on manufacturing and selling diagnostic kits, Transgene later shifted its focus to biotech research, including the development of vaccines, oncology treatments, and new drug delivery technologies. In 1999, the company achieved a major success by selling its genetically engineered recombinant Hepatitis B vaccine technology and patented process to the Serum Institute in Pune. Today, Transgene is listed on the Bombay Stock Exchange (BSE: TRABI – 526139) and has nearly three decades of experience and success. The company's product and technology portfolio includes offerings in oncology, oral drug delivery, and biogenerics. Transgene is dedicated to improving the lives of cancer patients through innovative drug solutions and enhancing the acceptability of vaccines and cancer drugs through novel oral drug delivery technologies. The company aims to maximize its pipeline's potential and contribute to global health through strategic partnerships and collaborations.
Legal Address
Plot Nos. 68, 69 & 70,, Anrich Industrial Area, IDA Bollaram
Medak; Telangana;
Postal Code: 502325
Contact Details: Purchase the Transgene Biotek Ltd. report to view the information.
Website: http://www.transgenebiotek.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service